内分泌学
内科学
催产素
碳水化合物代谢
葡萄糖摄取
脂肪组织
中枢神经系统
产热
柠檬酸合酶
受体
褐色脂肪组织
苹果酸脱氢酶
化学
生物
敌手
能量稳态
下丘脑
丙酮酸脱氢酶复合物
糖尿病
线粒体
葡萄糖稳态
催产素受体
信号转导
新陈代谢
交感神经系统
糖酵解
AMP活化蛋白激酶
受体拮抗剂
胞浆
2型糖尿病
下调和上调
酶
神经肽Y受体
葡萄糖转运蛋白
封锁
作者
Ting Shan Yao,Guoming Wu,Yu Zeng,Yinyin Xie,Xiao Cui,Qiongyue Zhang,Chaoying Yan,Zhicheng Cui,Hongyu Gong,Xiong Tianze,Xian Liang,Yan Zhang,Ruiqi Zheng,Hui Wang,Mingchun Gao,Peng Zhang,Ru Wang,Xiao Zhao,Zhihui Feng,Lei Xiao
标识
DOI:10.1016/j.xcrm.2026.102616
摘要
Bariatric surgery improves hyperglycemia in obesity and type 2 diabetes (T2D), yet its central mechanisms remain unclear. Through cerebrospinal fluid proteomic profiling of rats, we identify reduced central malate dehydrogenase 2 (MDH2) levels that correlate with surgery-induced restoration of normoglycemia. Central MDH2 blockade with the selective antagonist LW6 attenuates hyperglycemia under high-glucose conditions, independent of its enzymatic activity. Mechanistically, MDH2 inhibition activates oxytocinergic neurons in the hypothalamic paraventricular nucleus (PVN), promoting glucose disposal via sympathetic activation of brown adipose tissue (BAT) thermogenesis. Chemogenetic activation of PVN oxytocin neurons recapitulates this effect, while their silencing, oxytocin receptor blockade, or sympathetic inhibition abolishes LW6's metabolic benefits. PVN-specific Mdh2 deletion abrogates LW6's glucose-lowering effects and impairs systemic glucose homeostasis. LW6 demonstrates robust long-lasting glucose-lowering effects in a T2D mouse model. These findings establish MDH2 as a central glucose modulator and therapeutic target linking hypothalamic signaling to peripheral energy metabolism via an oxytocin-sympathetic nervous system (SNS)-BAT axis.
科研通智能强力驱动
Strongly Powered by AbleSci AI